Date post: | 19-Jan-2016 |
Category: |
Documents |
Upload: | lawrence-richards |
View: | 213 times |
Download: | 0 times |
Clinical PharmacokineticsClinical PharmacokineticsClinical PharmacokineticsClinical Pharmacokinetics
Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration of the drug (e.g., in blood).
Volume of distribution (Vd) Clearance (CL) Bioavailability (F) Half life
Volume of DistributionVolume of DistributionVolume of DistributionVolume of DistributionVolume of distribution (Vd) relates the amount of drug in the body to the plasma concentration of drug (C).
**The apparent volume of distribution is a calculated space and does not always conform to any actual anatomic space.**
note: Vd is the fluid volume the drug would have to be distributed in if Cp were representative of the drug concentration throughout the body.
)/(
)()(
LgC
gbodyindrugofAmountLVd
Drug Vd(L/70 kg body)
Chlroquine 13000
Warfarine 9.8
Clearance (CL)Clearance (CL)Clearance (CL)Clearance (CL)
Clearance is the most important property to consider when a rational regimen for long-term drug administration is designed.
The clinician usually wants to maintain steady-state drug concentrations known to be within the therapeutic range.
)/(
)/(neliminatioofRate)/(
LgC
hghLCL
Clearance of most drugs is constant over a range of
concentrations.
This means that elimination is not saturated and its
rate is directly proportional to the drug concentration:
this is a description of 1st-order elimination.
)/(min)/()/(neliminatio LgCLClhgofRate
First order elimination
0
100
200
300
400
500
0 100 200 300
Time (min)
Pla
sma
Con
cent
ratio
n(C
p)
Capacity limited elimination(zero order) Phenytoin, Ethanol and Aspirin
CK
vCL
m
m
CK
CVneliminatioofRate
m
max
CCLneliminatioofRate
Zero order elimination
0
50
100
150
200
250
300
0 20 40 60 80 100
Time(min)
Pla
sma
conc
entr
aion
(Cp)
Flow dependent elimination
Alprenolol Lidocaine
Amitriptyline Meperidine
Morphine Imipramine
Propranolol Isonizide
Verapamil Labetalol
CL in a given organ may be defined in terms of blood flow and [drug].
Q = blood flow to organ (volume/min)
CA = arterial drug conc. (mass/volume)
CV = venous drug conc.
rate of elimination = (Q x CA) - (Q x CV) = Q (CA-CV)
Extraction RatioExtraction RatioExtraction RatioExtraction Ratio
Division of the previous equation by the concentration of drug that enters the given organ of elimination yields an expression for clearance of the drug by the organ:
CLorgan = Q(CA-CV/CA) = Q x E
E is referred to as the extraction ratio
CCLneliminatioofRate
Rate of elimination = (Q x CA) - (Q x CV) = Q (CA-CV)
Half Life
Half life is the time required to change the plasma concentration to one-half or twice of its original value
CL
Vt d
693.0
2/1
Half Life
Half-life is the time taken for the concentration of drug in blood to fall by a half
0
10
20
30
40
50
60
70
80
90
100
110
0 1 2 3 4 5 6 7 8 9
Time (hours)
Co
nce
ntr
atio
n (
mg
/L)
Time to Steady State Time to steady state depends on half life
Half life DOES NOT depend on: Dose Dosage Interval
Tss = 4 x t½
Time to drug accumulation and elimination
)1( ktss eCC
2/1
)2ln(
tk
ktss eCC
)1( 2/1
2lnt
tSS eCC
Effect of half life on plasma concentration at the beginning of dosing
0
20
40
60
80
100
120
0 1 x 2 x 3 x 4 x 5 x
Number of half lives
Pla
sma
conc
(m
g/l)
Plasma conc
Effect of half life on plasma concentration at the end of dosing
0
5
10
15
20
25
0 x 1 x 2 x 3 x 4 x 5 x
No of half lives
Pla
sma
conc
(m
g/l)
Plasma conc
How do you change the plasma concentration?
To change the plasma concentration: Change the dose Change the dosage interval
Bioavailability
The fraction of unchanged drug reaching the systemic circulation following administration by any route.
IV
route
AUC
AUCFiltyBioavailib )(
The target concentration approaches to designing a rational dosage regimen
Maintenace Dose
Dosing ratess = Rate of eliminationss
Dosing ratess = CL X TCIf the bioavailability is less than 100 percent then
oralss F
rateDosingrateDosing
And if we want to give the drug intermittently:
Maintenace Dose = Dosing rate x Dosing interval
Loading Dose
Loading dose = Vd X TC
While the estimation of the amount of a loading dose may be quite correct, the rate of administration can be crucial in preventing excessive drug concentration, and slow administration of an intravenous drug (over minutes rather than seconds) is almost prudent practice
Good Luck